STP707

DRUG2 trials

Sponsors

Sirnaomics

Conditions

Healthy SubjectsSolid Tumor

Phase 1

Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

CompletedNCT05037149

SirnaomicsSolid Tumor

Start: 2021-11-01End: 2024-04-25Updated: 2026-07-29

A Study of STP707 Administered by IV in Healthy Subjects

CompletedNCT05309915

SirnaomicsHealthy Subjects

Start: 2022-02-28End: 2022-08-30Updated: 2024-03-18